Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 42291-965

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 42291-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 (965 90)

Packaging label for Valsartan and Hydrochlorothiazide Tablets, USP, 80 mg/12.5 mg film-coated oral tablets. The label shows that the product is Rx only, contains 30 tablets, and is labeled by AvKARE. It includes a barcode, NDC 42291-965-90, and dosage instructions along with storage and manufacturing information.*

FDA Label Image

6 (966 90)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 160 mg / 12.5 mg, film-coated oral tablets. The package contains 30 tablets and is labeled by AvKARE. The label includes dosage information and storage instructions, along with a barcode and a QR code on a white background with red and black text.*

FDA Label Image

7 (967 90)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg, film-coated oral tablets. The label includes dosage information, storage instructions, a 30-tablet quantity indication, and the AvKARE logo as the labeler. The label also contains a barcode and manufacturing details.*

FDA Label Image

8 (968 90)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/12.5 mg, film-coated tablets. The label indicates a quantity of 90 tablets and is from the labeler AvKARE. It includes storage instructions and a barcode, with emphasis on the product name and strength.*

FDA Label Image

9 (969 90)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg strength. The label indicates 90 film-coated tablets in the package, with dosage information and storage instructions. The labeler is AvKARE, and it includes a barcode and a QR code.*

FDA Label Image

Figure 1 (Valsartan And Hydrochlorothiazide Tablets Usp 1)

A line graph depicting the percentage of patients achieving systolic blood pressure (SBP) below 140 mmHg, plotted against baseline SBP values ranging from 140 to 180 mmHg. Four treatment groups are compared: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, each represented by distinct markers. The graph shows response trends for these treatments over increasing baseline SBP.*

FDA Label Image

Figure 2 (Valsartan And Hydrochlorothiazide Tablets Usp 2)

A line graph showing percentage change in DBP-90 (mmHg) versus baseline DBP (mmHg) for four treatments: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. Each treatment is represented by distinct symbols in the legend, illustrating comparative effects over a range of baseline DBP values from 90 to 110 mmHg.*

FDA Label Image

Figure 3 (Valsartan And Hydrochlorothiazide Tablets Usp 3)

A line chart showing the percentage of systolic blood pressure (SBP) under 130 mmHg by baseline SBP levels. The chart compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, with each group represented by different markers.*

FDA Label Image

Figure 4 (Valsartan And Hydrochlorothiazide Tablets Usp 4)

A line graph comparing the percentage of diastolic blood pressure less than 80 mmHg across baseline diastolic blood pressure (DBP) levels from 90 to 110 mmHg for four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The graph shows Valsartan and Hydrochlorothiazide combination with the highest percentage reduction, followed by Valsartan, Hydrochlorothiazide, and Placebo.*

FDA Label Image

Valsartan Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 5)

Chemical structure of Valsartan, the active ingredient depicted in the diagram with distinct connected rings, chains, and functional groups representing its molecular composition.*

FDA Label Image

Hydrochlorothiazide Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 6)

Chemical structure of the active ingredient Valsartan and Hydrochlorothiazide, illustrating the molecular arrangement of atoms including sulfur, nitrogen, chlorine, and carbon within the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.